Bio-En Holdings Corp.
CIK:0001568139|SEC Filings
STATEMENTS OF OPERATIONS - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| General and administrative expenses | ||||
| Filing fees | $ 4,455 | $ 4,522 | $ 15,207 | $ 13,149 |
| Other costs | 0 | 185 | 145 | 570 |
| Professional fees:- | ||||
| - Accounting | 6,000 | 6,000 | 18,000 | 18,000 |
| - Auditor's fee | 3,000 | 3,000 | 9,000 | 9,000 |
| - Legal fees | 3,000 | 3,000 | ||
| Total operating expenses | 16,455 | 13,707 | 45,352 | 40,719 |
| Provision for Write Down of Investment | 0 | (15,000) | (1,000) | (30,000) |
| Net profit/ loss | $ (16,455) | $ 1,293 | $ (44,352) | $ (10,719) |
| Net profit/loss per common share - basic and diluted | ||||
| Net loss per share attributable to common stockholders, basic | $ 0 | $ 0 | $ 0 | $ 0 |
| Net loss per share attributable to common stockholders, diluted | $ 0 | $ 0 | $ 0 | $ 0 |
| Weighted-average number of common shares outstanding, basic | 77,350,003 | 77,350,003 | 77,350,003 | 77,350,003 |
| Weighted-average number of common shares outstanding, diluted | 77,350,003 | 77,350,003 | 77,350,003 | 77,350,003 |
STATEMENT OF CASH FLOWS - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Cash Flows from Operating Activities | ||||
| Net loss | $ (16,455) | $ 1,293 | $ (44,352) | $ (10,719) |
| Changes in operating assets and liabilities: | ||||
| Sundry Debtors and prepayments | 0 | 15,000 | ||
| Accounts payable and accrued liabilities | 19,398 | 10,210 | ||
| Accounts payable - related party | 11,000 | 0 | ||
| Net cash used in operating activities | (13,954) | 14,491 | ||
| Cash Flows from Investing Activities - Provision for Write Down of Investment | 0 | 0 | ||
| Cash Flows from Financing Activities | 0 | 0 | ||
| Increase/Decrease in cash and cash equivalents | (13,954) | 14,491 | ||
| Cash and cash equivalents at beginning of the period | 15,633 | 11,710 | ||
| Cash and cash equivalents at end of the period | $ 1,679 | $ 26,201 | $ 1,679 | $ 26,201 |
BALANCE SHEETS - USD ($) |
Sep. 30, 2022 |
Dec. 31, 2021 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 1,679 | $ 15,633 |
| Sundry debtors and prepayments | 0 | 0 |
| Total current assets | 1,679 | 15,633 |
| TOTAL ASSETS | 1,679 | 15,633 |
| Current liabilities: | ||
| Accounts payable and accrued liabilities | 143,397 | 123,999 |
| Loans from related parties | 387,250 | 376,250 |
| Total current liabilities | 530,647 | 500,249 |
| Total liabilities | 530,647 | 500,249 |
| Stockholders' Equity (Deficit) | ||
| Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding | ||
| Common stock, $0.0001 par value; 250,000,000 shares authorized; 77,350,003 shares issued and outstanding at September 30, 2022 and at December 31, 2021 | 7,735 | 7,735 |
| Additional paid-in capital | 352,681 | 352,681 |
| Accumulated deficit | (889,384) | (845,032) |
| Total Stockholders' Equity (Deficit) | (528,968) | (484,616) |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ 1,679 | $ 15,633 |